H. pylori infection RedHill Biopharma Talicia
RedHill Biopharma completes enrolment in Phase III trial of Talicia
RedHill Biopharma has completed patient enrolment in the Phase III ERADICATE Hp2 study of Talicia (RHB-105) in comparison with a…
RedHill Biopharma has completed patient enrolment in the Phase III ERADICATE Hp2 study of Talicia (RHB-105) in comparison with a…